Evidence map›Paper›PMID 37987263›Full record

ReviewDiseases (Basel, Switzerland)2023

The Effectiveness and Safety of Long-Term Macrolide Therapy for COPD in Stable Status: A Systematic Review and Meta-Analysis.

Kazunori Nakamura, Yukio Fujita, Hao Chen, Kohei Somekawa, Fumihiro Kashizaki, Harumi Koizumi, Kenichi Takahashi, Nobuyuki Horita, Yu Hara, Shigeo Muro and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Diseases (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Kazunori NakamuraDepartment of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto 861-4193, Japan.ORCID 0000-0001-8386-3052
Yukio FujitaDepartment of Respiratory Medicine, Nara Medical University, Nara 634-8522, Japan.
Hao ChenDepartment of Pulmonology, Yokohama City University Hospital, Yokohama 236-0004, Japan.ORCID 0000-0003-3074-2235
Kohei SomekawaDepartment of Pulmonology, Yokohama City University Hospital, Yokohama 236-0004, Japan.
Fumihiro KashizakiDepartment of Respiratory Medicine, Yokohama Minami Kyousai Hospital, Yokohama 236-0037, Japan.ORCID 0000-0003-0214-1571
Harumi KoizumiDepartment of Respiratory Medicine, Yokohama Minami Kyousai Hospital, Yokohama 236-0037, Japan.
Kenichi TakahashiDepartment of Respiratory Medicine, Yokohama Minami Kyousai Hospital, Yokohama 236-0037, Japan.
Nobuyuki HoritaChemotherapy Center, Yokohama City University Hospital, Yokohama 236-0004, Japan.
Yu HaraDepartment of Pulmonology, Yokohama City University Hospital, Yokohama 236-0004, Japan.
Shigeo MuroDepartment of Respiratory Medicine, Nara Medical University, Nara 634-8522, Japan.ORCID 0000-0001-7452-9191
Takeshi KanekoDepartment of Pulmonology, Yokohama City University Hospital, Yokohama 236-0004, Japan.
Yokohama City University Hospital · JPYokohama Minami Kyosai Hospital · JPNara Medical University · JPSaiseikai Kumamoto Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

azithromycinCOPDerythromycinexacerbationmacrolide

Identifiers

PMID37987263
PMCPMC10660475
OpenAlexW4387972906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.